PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.31%
Revenue growth above 1.5x TSM's 6.94%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
149.98%
Gross profit growth above 1.5x TSM's 8.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
197.95%
EBIT growth above 1.5x TSM's 6.42%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
197.95%
Operating income growth above 1.5x TSM's 6.42%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
202.16%
Net income growth above 1.5x TSM's 16.53%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
204.17%
EPS growth above 1.5x TSM's 17.42%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
200.00%
Diluted EPS growth above 1.5x TSM's 16.77%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.85%
Share count expansion well above TSM's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
5.08%
Diluted share count expanding well above TSM's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
4.59%
OCF growth under 50% of TSM's 30.71%. Michael Burry might suspect questionable revenue recognition or rising costs.
6.18%
FCF growth under 50% of TSM's 560.91%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
496.50%
10Y revenue/share CAGR above 1.5x TSM's 147.68%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
58.28%
5Y revenue/share CAGR at 50-75% of TSM's 82.13%. Martin Whitman would worry about a lagging mid-term growth trajectory.
5.57%
3Y revenue/share CAGR under 50% of TSM's 31.33%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
762.18%
OCF/share CAGR of 762.18% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
29321.27%
5Y OCF/share CAGR above 1.5x TSM's 74.27%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-53.15%
Negative 3Y OCF/share CAGR while TSM stands at 32.99%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
550.14%
Net income/share CAGR above 1.5x TSM's 164.40% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
275.60%
5Y net income/share CAGR above 1.5x TSM's 98.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-3.13%
Negative 3Y CAGR while TSM is 60.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1477.85%
Equity/share CAGR of 1477.85% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
97.57%
5Y equity/share CAGR above 1.5x TSM's 35.45%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
25.94%
3Y equity/share CAGR above 1.5x TSM's 10.45%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.03%
Our AR growth while TSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-0.56%
Inventory is declining while TSM stands at 7.51%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.01%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.93%
75-90% of TSM's 8.86%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-1.20%
We’re deleveraging while TSM stands at 39.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
2.64%
R&D dropping or stable vs. TSM's 11.75%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
16.24%
SG&A growth well above TSM's 17.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.